McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. February 5, 2026 – Often in the policy realm (and especially in the health space), major reforms are ...
Pharmacy benefit manager (PBM) reform has been an active and evolving area for policymakers in Washington, D.C. for many years but reform efforts have noticeably picked up pace in 2026. Recent actions ...
Transparency mandates require detailed disclosure of rebates, spread pricing, fees, and reimbursement methodologies, expanding plan sponsor audit rights and increasing CMS oversight of PBM reporting ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’re frustrated with your pharmacy benefit manager ...
Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack competitive conditions. Learnings from transparency will shape future drug pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results